Author

Mélanie Prague

Institut national de recherche en sciences et technologies du numériqueORCID 0000-0001-9809-7848Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:non-human primate· 2 Research Focus:benchmarking· 1 Research Focus:host-pathogen & immune response· 1 Approach:mechanistic / dynamical model· 1 Assay:proteomics· 1 Approach:simulation· 1 Approach:statistical model· 1

Frequent Co-Authors

Alison L. HilliD· 1 shared Chloé PasiniD· 1 shared Dan H. BarouchiD· 1 shared Francis RelouzatiD· 1 shared Irène BalelliiD· 1 shared James B. WhitneyiD· 1 shared Jeffrey M. GeroldiD· 1 shared Jonathan Z. LiiD· 1 shared

Activity by Year

2019-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Alison L. HillORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Joint mechanistic modeling of viral and antibody responses to vaccines in non-human primates to quantify SARS-CoV-2 mechanistic correlates of protection

Marie Alexandre, Romain Marlin, Laëtitia Bossevot, Mariangela Cavarelli, Nathalie Dereuddre‐Bosquet, Francis Relouzat, Mireille Centlivre, Roger Le Grand, Rodolphe Thiébaut, Yves Lévy, Mélanie Prague

This study develops a mechanistic model of viral and antibody dynamics in non-human primates to quantify correlates of protection against SARS-CoV-2 infection.

bioRxiv · Jan 16, 2026 · PreprintImmunology

Viral rebound kinetics following single and combination immunotherapy for HIV/SIV

Mélanie Prague, Jeffrey M. Gerold, Irène Balelli, Chloé Pasin, Jonathan Z. Li, Dan H. Barouch, James B. Whitney, Alison L. Hill

This study analyzes viral rebound kinetics after immunotherapy in HIV/SIV, finding that vaccines and TLR7-agonists reduce latent reservoir reactivation and boost immune responses.

bioRxiv · Aug 1, 2019 · PreprintSystems Biology